Inmode Ltd

InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. It also designs, develops, manufactures and markets non-invasive medical aesthetic products that target a array of procedures including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture and superficial benign vascular and pigmented lesions. The company was founded by Moshe Mizrahy and Michael Kreindel on January 2, 2008 and is headquartered in Yokneam, Israel.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

InMode reports record revenue, plans global expansion for growth

InMode's strong financial performance in Q4 and full year 2022, driven by successful product launches and global expansion efforts, positions the company for continued growth. Despite challenges in pinpointing market penetration, opportunities lie in new product launches and untapped physician markets.

InMode reports robust Q1 earnings, eyes international expansion and talent

InMode delivered strong Q1 2023 results, driven by revenue growth, international expansion, and strategic hiring practices, positioning the company for continued success.
While facing challenges such as rising operating expenses and talent acquisition complexities, InMode's focus on quality, innovation, and financial strength presents opportunities for sustainable growth.
By leveraging opportunities in talent acquisition, product innovation, and international expansion, InMode can enhance market competitiveness and drive long-term value creation.
Overall, InMode's performance, strengths, and strategic outlook indicate a positive trajectory for future growth and profitability, supported by a solid financial foundation.

InMode achieves record Q2 earnings, eyes global expansion and innovation

InMode's strong financial performance, global expansion, and focus on innovation position it well for future growth. While facing challenges in managing increased expenses and scaling sales, the company's strategic investments and market positioning offer promising opportunities for expansion and market leadership.

InMode reports steady Q3 growth amidst challenges and opportunities

InMode's Q3 performance reflects resilience amid industry seasonality and macro challenges, with revenue growth and strong margins.
The company's focus on innovation, IP protection, and strategic acquisitions positions it for sustained leadership and growth.
Challenges in leasing processes and legal battles require proactive management, but opportunities in M&A and product growth remain.
Despite uncertainties for 2024, InMode's strategic initiatives and market presence offer a foundation for future success.

InMode reports record 2023 revenue, eyes international expansion and M&A

InMode navigated industry challenges in 2023 with resilience, focusing on innovation, global expansion, and cost management. Despite facing headwinds, the company remains optimistic about growth opportunities, leveraging its strong financial position and strategic initiatives for future success.

InMode reports Q1 revenue of $80.3M, adjusts guidance for 2024

InMode faces challenges from industry headwinds and manufacturing delays but shows strength in new platform launches and North America performance.
Opportunities lie in strategic initiatives, market demand confidence, and growth potential from new platforms.
Guidance adjustments reflect proactive measures to navigate uncertainties and drive future growth.
Overall, InMode remains resilient amidst challenges, poised for growth with strategic focus areas.

InMode reports Q2 revenue of $86.4 million, adjusts 2024 guidance

InMode faces challenges with declining demand for treatments and international sales, but is leveraging new platform launches and cost management to drive performance. The company is adapting to market conditions and geopolitical issues to capitalize on growth opportunities.

InMode reports Q3 revenue of $130.2M, revises guidance amid challenges

InMode faced challenges from macroeconomic headwinds, impacting international sales and necessitating a revision of full-year guidance.
Despite these challenges, the company demonstrated strong operational performance with high gross margins and strategic management changes.
Opportunities lie in new platform adoption, market realignment, and leveraging the strong cash position for future growth.
Overall, InMode remains well-positioned to navigate challenges and capitalize on opportunities for sustainable growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

YOKNEAM, Israel, Aug. 5, 2020 /PRNewswire/ -- InMode Ltd.

InMode Reports Second Quarter 2020 Financial Results; Quarterly Revenues of $30.8 Million, GAAP and *Non-GAAP Diluted Earnings per Share of $0.21 and $0.24

YOKNEAM, Israel, Aug. 3, 2020 /PRNewswire/ -- InMode Ltd.

InMode to Present at Upcoming Virtual Conferences in August

LAKE FOREST, Calif., July 27, 2020 /PRNewswire/ -- InMode Ltd.

InMode Technologies Win Major Beauty Awards

InMode (INMD) saw a big move last session, as its shares jumped more than 10% on the day, amid huge volumes.

InMode (INMD) Surges: Stock Moves 10.6% Higher

The medical device maker's boosting its second-quarter guidance.

Why InMode Shares Are Soaring 13.7% Today

InMode (INMD) closed the most recent trading day at $28.07, moving +0.36% from the previous trading session.

InMode (INMD) Gains But Lags Market: What You Should Know

InMode (INMD) closed at $31.15 in the latest trading session, marking a +1.1% move from the prior day.

InMode (INMD) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, InMode (INMD) closed at $31.15, marking a -1.61% move from the previous day.

InMode (INMD) Dips More Than Broader Markets: What You Should Know

InMode: A Look Into The Fundamentals Reveals A Clear Undervaluation

InMode Ltd. (INMD) CEO Moshe Mizrahy on Q1 2020 Results - Earnings Call Transcript

Cardlytics

Health Catalyst Inc

Inseego

LivePerson

Maxar Technologies

Plug Power

Stitch Fix

Tabula Rasa Healthcare

These small-cap stocks could rise by 1,000% or more in the 2020s, making them some of the best stocks to buy for the next 10 years.

10 Small-Cap Stocks to Buy for HUGE Gains in the Next 10 Years

InMode's (INMD) Q1 performance is likely to have been driven by developments in business segments amid coronavirus-led supply disruptions.

InMode (INMD) to Post Q1 Earnings: What's in the Offing?

Farfetch

SmileDirectClub

Some high-growth names in the beauty and fashion industries are trading at a discount.

3 Dirt-Cheap Stocks That Are an Eye-Popping Bargain

Blucora

DHT Holdings

Enphase Energy

Profitability analysis is one of the best ways to evaluate the prospects of a company.

4 Stocks With  High Net Income Ratio to Scoop Up

Cardinal Health

DaVita

Ensign Group

Integer Holdings

Here are 5 ways to make the most of a difficult market.

5 Stocks to Buy for 5 Good Reasons

Algonquin Power & Utilities

American States Water

Grocery Outlet

Regeneron Pharmaceuticals

US Foods Holding

The current economic slowdown led by rise in coronavirus cases calls for investing in defensive stocks.

6 Defensive Stocks Worth Buying as Coronavirus Cases Rise

Bull of the Day: InMode Ltd. (INMD)

InMode Ltd. (INMD) CEO Moshe Mizrahy on Q4 2019 Results - Earnings Call Transcript

InMode (INMD) closed at $44.14 in the latest trading session, marking a -0.07% move from the prior day.

InMode (INMD) Stock Moves -0.07%: What You Should Know

InMode's (INMD) Q4 performance is likely to have been driven by developments in business segments.

InMode (INMD) to Post Q4 Earnings: What's in the Cards?

InMode (INMD) closed the most recent trading day at $42.81, moving -0.23% from the previous trading session.

InMode (INMD) Stock Moves -0.23%: What You Should Know

InMode's BodyTite Procedure Is Less Attractive Than Investors Assume

Microsoft

Signet Jewelers

Tandem Diabetes Care

Taiwan Semiconductor Manufacturing

Signet Jewelers, Microsoft, Tandem Diabetes, InMode and Taiwan Semi were our top stock trades for Friday -- and here's why.

5 Top Stock Trades for Friday: SIG, MSFT, TNDM

Beyond Meat

Cortexyme Inc

IGM Biosciences Inc

Karuna Therapeutics Inc

Nextcure

Palomar

Shockwave Medical

Turning Point Therapeutics

Karuna Therapeutics, NextCure, and Cortexyme aren’t household names when it comes to investors looking at initial public offerings (IPOs), but they’ve been generating big-time returns for investors who didn’t buy into the hype of more familiar names like Uber or Lyft.

Non-Household Names Topped the List of IPO Winners in 2019

Applied Therapeutics Inc

Aprea Therapeutics

BioNTech SE

Glaukos

Rapt Therapeutics Inc

Incredibly, they're almost all health stocks, including 7 biotechs, an eye surgery platform, and a medical device company.

News for Inmode Ltd Stock (INMD)